Nicole Fawcett
Director of Communications, University of Michigan Rogel Cancer

Fawcett leads a team of communicators who produce targeted, innovative communication for the Rogel Cancer Center’s research and clinical enterprises. Prior to Michigan Medicine, Fawcett was a reporter at the Detroit News and editor for a web-based community for people with disabilities.

Nicole Fawcett photo
cells under microscope #D render particles
Health Lab
Study demonstrates a novel approach to target enhancer-addicted cancers
A chromatin degrader stops transcription factors from driving cancer, which may serve as a potential treatment approach for over 90% of prostate cancers.
blue xray throat tumor lump with lab note written in blue with yellow overlay on bottom right
Health Lab
Two markers help predict head and neck cancer prognosis
HPV circulating tumor DNA and MRI/PET imaging markers predicted which tumors would respond to chemoradiation as early as two weeks into treatment.
microscopic colorful rainbow cells black background and yellow badge on bottom right and blue lettering saying lab notes
Health Lab
Researchers find promising new approach to stop intestinal problems caused by immune cells
New research suggests gastrointestinal diseases caused by immune system T cells could be mitigated by bolstering a common enzyme.
gold scale doctors with woman on one side and male on other side
Health Lab
Among physicians, men make more than women. How do we change that?
A new perspective looks at the built-in bias within the factors that drive physicians’ salaries and makes recommendations for how institutions can close the gap.
Doctor in room reaching out smiling
Health Lab
Treatment enhances anti-leukemia effect of bone marrow transplant, reduces recurrence, study finds
In a clinical trial, adding interferon treatment with a bone marrow transplant bolstered outcomes for patients with advanced, high-risk leukemia.
doctor and researchers in lab coat and white coat in lab looking at syringe injection
Health Lab
Researchers uncover way to harness the power of immunotherapy for advanced prostate cancer
A protein called PIKfyve impacts multiple processes involved in metabolism and cell death; blocking it is key to making immunotherapy work in prostate cancer.
woman working from home in three different scenes being stressed out in colors blue grey and yellow
Health Lab
‘Seizing a disruptive opportunity’ to improve gender equity in medicine
Women have borne a disproportionate burden during the COVID-19 pandemic, and women in medicine are no exception. Can we seize this disruptive opportunity to improve gender equity in medicine?
blue kidney cancer cell microscopic
Health Lab
Analysis Reveals How Kidney Cancer Develops and Responds to Treatment
Findings offer clues to why some types of renal cell carcinoma respond to immunotherapy while others do not.
cancer cell in lung that's purple in microscopic view
Health Lab
Study Suggests Path to Blocking Common Genetic Driver of Lung Cancer
Stopping the interaction between KRAS and the protein AGO2 slowed tumor growth in mouse models.
purple HPV cells floating
Health Lab
HPV Fuels Uptick in Head and Neck Cancers in Taiwan, Study Finds
Vaccines and other policies could help keep in check a disease that’s becoming increasingly common worldwide.
Doctor in whitecoat giving an exam with stethocope on patient
Health Lab
6 Key Facts About Clinical Trials
Why you should consider participating in a clinical trial and what to expect from the experience.
Man holding a dog outside
Health Lab
How One Caregiver Keeps his Dad Safe from COVID-19
I’m a protector. Keeping Dad healthy, really, that’s my motivation.
Interaction between STC1 and CRT within a cell
Health Lab
How a Little-Known Glycoprotein Blocks a Cancer Cell’s Immune Response
Targeting this inside-the-cell checkpoint could potentially improve response to cancer immunotherapy.
liver cancer red and orange in a blue body virtual drawing
Health Lab
Study Explains Why Patients with Cancer Spread to the Liver Have Worse Outcomes
The liver siphons critical immune cells to render immunotherapy ineffective; radiation to the liver may block this process.
man looking in microscope in lab
Health Lab
Prostate Cancer Regulator Plays Role in COVID-19, Providing a Promising Treatment Lead
Clinical trials underway are testing whether drugs that target the androgen receptor – successful in controlling prostate cancer – could also work against the coronavirus.
  • 2
  • 3
  • 4